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Abstract:  
Kinetic studies on the stability of two non-steroids anti-inflammatory drugs (NSAIDs), ibuprofen and mefenamic 
acid, in pure water and activated sludge indicated that both pharmaceuticals were resistant to degradation for one 
month. The efficiency of sequential advanced membrane technology wastewater treatment plant towards removal of 
both drugs from wastewater was investigated. The sequential system included activated sludge, ultrafiltration 
(hollow fiber membranes with 100 kDa cutoff, and spiral wound membranes with 20 kDa cutoff), activated carbon 
column and reverse osmosis (RO).  The overall performance of the integrated plant demonstrated complete removal 
of ibuprofen and mefenamic acid from spiked wastewater samples. Activated carbon column was the most effective 
component in removing these NSAIDs with a removal efficiency of 98.8% for both ibuprofen and mefenamic acid. 
Batch adsorption of both NSAIDs by activated charcoal and a composite micelle (octadecyltrimethylammonium 
(ODTMA)–clay (montmorillonite) was determined at 25 ˚C. The results revealed that both adsorptions fit Langmuir 
isotherm with Qmax of 66.7 mg/g and 62.5 mg/g for ibuprofen using activated carbon and clay-micelle complex, 
respectively, and with Qmax of 90.9 mg/g and 100.0 mg/g for mefenamic acid using activated charcoal and clay-
micelle complex, respectively. These results suggest that an integration of ODTMA-clay-micelle complex column in 
wastewater treatment plant is highly promising and can lead to an improvement of the removal efficiency of these 
drugs from wastewater. 
Keywords: Ibuprofen;  Mefenamic acid; Wastewater treatment; Stability in sludge; HF-membranes; Activated 
carbon; Micelle–clay complex. 
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1. Introduction 
The consumption of water over the world is increasing, and 
the demand on water resources for household, commercial, 
industrial, and agricultural purposes are in rise as well. This 
soaring in demand is due to a rapidly expanding population, 
industrial expansion, and the need to expand irrigated 
agriculture. However, this expanding in population is offset by 
a decrease in fresh water resources and low water availability 
[1]
. 
In the Middle East, in general, and in Palestine in particular, 
water resources are very limited
[2-4]
.This situation will be 
aggravated in the future, since the water balance gap between 
the available water supplies and water demands, as a result of 
population growth, rapid urbanization and industrial 
associated with living standards improvement, will increase. 
This gap along with a contamination of ground water and 
surface water by industrial effluents, and agricultural 
chemicals, will cause serious shortage of fresh water and high 
production of wastewater 
[1, 4-7]
. 
The water consumption in Palestine which is considered as a 
semi-arid country is divided among three principle sectors: (1) 
agricultural sector consumes around 70%, and represents the 
largest consumer of water in Palestine, (2) domestic sector 
which consumes about 27% of the water consumption, and 
finally (3) industrial sector which consumes only 3% of the 
total water use (Figure 1, appendix A) [5]. 
The ground water is the main source of fresh water in 
Palestine, the aquifer system comes from three main ground 
water drainage basins, the first in the western, the second in 
the northeastern, and the third in the eastern part of the West 
Bank (Palestine).The sources of fresh water in Palestine suffer 
from Israeli confiscation and control [8].  
The surface water is considered to be very important to the 
Palestinians due to complete Israeli confiscation of the Jordan 
River basin, which is the only source of surface water in 
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Palestine [2]. This situation requires preserving all water 
supplies that currently exist, and control water usage and use it 
efficiently, minimize water pollution and water contamination 
by reducing wastewater flows, and finding solutions for 
disposal, treatment and recycling of wastewater. 
Reducing wastewater flows which is the major source of 
pollution of fresh water will contribute in increasing adverse 
effects, because untreated or partially treated wastewater 
causes health and environmental hazard [9-10].Therefore, the 
Palestinian National Authority (PNA) and the Palestinian 
Water Authority (PWA) have put the reuse of wastewater as a 
major priority in their agenda [5]. 
 
1.1 Wastewater management in Palestine 
The major sources of wastewater pollution can be classified as 
municipal, industrial and agricultural. Municipal water 
pollution consists of wastewater from homes and commercial 
establishments. The main goal of treating wastewater is to 
reduce its adverse content of suspended solids, oxygen-
demanding materials, dissolved inorganic compounds and 
harmful bacteria [11]. In Palestine during the occupation 
period, wastewater sector was much neglected; as a result the 
status of wastewater sector is characterized by poor sanitation, 
insufficient treatment, and unsafe disposal of untreated or 
partially treated wastewater into the environment. 
Approximately 60% of the houses in urban communities are 
connected to sewage systems, some large towns and cities 
have no sewage system at all, and wastewater is discharged 
into septic tanks and/or emptied into valleys (wades), therefore 
the situation of sewage system is extremely critical [12]. In the 
villages no sewage networks exist, and wastewater is collected 
in cesspits or septic tanks, most of Israeli settlements in the 
West Bank discharge the wastewater in wades without any 
treatment and only 1% of the collected wastewater are 
properly treated [13]. 
The existing urban sewage collection and treatment facilities 
are constrained by limited capacity, poor maintenance, process 
malfunction and lack of experienced or a poor trained staff 
[14-15]. Generally water reuse application can serve many 
purposes, such as landscape irrigation which is considered as 
the largest field in using reclaimed wastewater [1, 16-
17].Therefore, in order to achieve a sustainable and effective 
application of water reuse, the treatment system process must 
be able to isolate industrial toxins, pathogens carbon, and 
nutrient to prevent public health hazards that might be caused 
by wastewater reuse [18]. 
The treated or partially treated wastewater that is discharged in 
many areas in the West Bank is presently used for irrigation 
purposes, however, this use still in small-scale projects due to 
the lack of experience that is required for safe usage [18]. The 
reuse of treated wastewater must be combined with strategies, 
to prevent health and environment risks from pathogens, 
heavy metals, pesticides, and pharmaceuticals. Therefore, the 
Palestinian National Authority (PNA) has commenced acting 
aggressively in the field of water and wastewater management 
in terms of legislation, policies, and strategies, design and 
implementation of projects, as well as approving 
environmental laws that regulate the wastewater usage. 
Furthermore, the Palestinian Water Authority (PWA) has 
established guidelines extracted from rules issued by the 
World Health Organization (WHO) to ensure protection of the 
public health and environment from discharge of untreated or 
inadequately treated wastewater effluents [19-21]. 
The efficient sewage treatment systems are urgently needed in 
Palestine, because appropriate and sustainable sewage 
treatment technologies will help to preserve biodiversity and 
maintain healthy ecosystems [5]. Various methods for 
wastewater treatment have been used in some of the 
Mediterranean countries, many are conventional such as 
activated sludge and biofilters and others slightly less 
conventional, such as oxidation ditches, aerated lagoons and 
natural treatment system such as waste stabilization ponds [6]. 
In Palestine, two types of treatment plant systems: 
conventional and less conventional are used; stabilization 
ponds for small communities, tickling filter, oxidation ditches, 
and activated sludge for large scale community. Table S1 
(Supplementary data) lists the current status of existing and 
planned wastewater treatment in the West Bank [5]. 
The main goal of this research study was to investigate the 
performance of advanced treatment technologies which 
include integration of activated sludge process with ultra-
filtration membranes (hollow fiber and spiral wound 
membranes), activated carbon adsorbent, micelle-clay filters, 
and reverse osmosis for the removal of some non-steroidal 
anti-inflammatory drugs, such as ibuprofen and mefenamic 
acid.  
In this study the efficiency of the integrated membranes 
assembled in the wastewater treatment plant at Al-Quds 
University was tested for removing representative examples of 
non-steroidal anti-inflammatory drugs (NSAIDs) [22] namely 
ibuprofen (structure 1 in Figure 2, appendix A) and 
mefenamic acid (structure 2 in Figure 2, appendix A)  from 
wastewater. A clay micelles-complex, 
octadecyltrimethylammonium (ODTMA, structure 3 in Figure 
2, appendix A) and activated charcoal membranes were also 
included in the membranes plant system. 
It should be indicated that ibuprofen and mefenamic acid are 
extensively used as non-prescription drugs, with an annual 
consumption of several hundreds of tones in developed 
countries, as they are widely used for painful and 
inflammatory conditions [22]. 
1.2 Wastewater 
Wastewater contains the following broad grouping of 
constituents: 1) organic matter such as feces, hair, food, vomit, 
paper fibers, plant material, urea, 2) nutrients (nitrogen, 
phosphorus potassium), 3) inorganic matter (dissolved 
mineral), 4) toxic chemicals such as pharmaceuticals and 
drugs and 5) pathogens. This composition in fact may differ 
from community to community, it depends on the source. For 
example the composition of wastewater coming from 
residential communities is not the same as in areas having 
industrial units, the time also play a vital role in wastewater 
composition, because the largest amount of water entering 
municipal wastewater system during the diurnal interval and 
holidays, other factors such as the size of community may also 
affect the wastewater composition [23-24]. 
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1.2.1 Definition and Characteristics of Wastewater 
In general wastewater can be defined as any water that has 
been used, and affected in quality by anthropocentric influence 
[25]. The more specific definition of wastewater is a 
combination of water carried wastes removed from residence, 
institution, commercial, industrial establishments, and ground 
water [23].Wastewater is about 99% water by weight referred 
as influent, and the remaining one percent includes suspending 
and dissolved organic substances, as well as microorganisms 
[25, 26], but this ratio may varies according to the activity that 
wastewater resulted from, but the constituents ratio is not less 
than 95% water, as water is often added during the flushing to 
carry the waste down a drain [23]. The wastewater sources can 
be domestic wastewater or “sewage” and this type resulted 
from homes, commercial places, and farms [27]. Domestic 
wastewater can be divided into two elements, black water 
which originates from toilets and kitchens and is highly 
contaminated and grey water which originates from baths, 
showers, wash basins and washing machine and is generally 
less contaminated. Grey water makes up to 40% - 60% of the 
total domestic wastewater volume [28]. Industrial/commercial 
wastewater is flow generated and discharged from 
manufacturing and commercial activities, a combination of 
domestic and industrial wastewater constituents is known as 
municipal wastewater [29]. The principal elements for which 
wastewater is prescribed are the physical, chemical, and 
biological elements, the physical parameters include total solid 
contents which consist of total suspended solid (TSS) and total 
dissolved solids (TDS), particle size distribution, turbidity, 
temperature, conductivity, transmittance, density, color and 
odor. The chemical parameters include biochemical oxygen 
demand (BOD), chemical oxygen demand (COD) and all of 
these parameters are considered organic chemical parameters, 
and other parameters like hardness, pH, salinity, ionized ions 
and metals are considered inorganic chemical parameters as 
well as the biological parameters such as coliform, fecal 
coliforms, viruses, and pathogens [29-31].  
1.2.2 Wastewater treatment process 
Treatment facilities incorporate numerous processes, which in 
combination achieve the desired water quality objectives. 
These processes involve the separation, removal and disposal 
of pollutants present in wastewater. The treatment of 
wastewater is accomplished by four basic methods or 
techniques; physical, mechanical, biological and chemical. 
The physical method of treatment is unit operations used in 
wastewater treatment which include; flow-metering, 
screening, mixing, sedimentation, accelerating gravity settling, 
floatation, filtration gas transfer and volatilization. Mechanical 
treatment methods involve the use of machines and chemical 
treatment methods include many processes such as chemical 
precipitation, adsorption, disinfection and dechlorination [11, 
29]. Water treatment usually consists of four stages: 
preliminary, primary, secondary, and tertiary. But the primary 
and secondary stages are considered the major steps, and the 
tertiary stage is required to achieve complete removal for 
pollutants which have not been removed by secondary 
treatment [26]. 
 
1.2.2.1 Preliminary treatment 
The influent that flows to treatment plant contains pieces and 
wood, rags, plastic and other debris in addition to sand, 
eggshells and other coarse inorganic materials, as well as 
organic matter from household, industrial, commercial and 
institutional water use. All these components are removed 
through combination of screening and settling [29-30, 32]. 
 
1.2.2.2 Primary treatment 
In primary treatment, the objectives such as large debris, grit 
and sands from wastewater by screening, settling, or floating 
are physically removed [26]. During primary treatment 
wastewater flows into and through large settling tanks or 
clarifiers where the flow velocity is reduced. Here initial 
separation occurs, with 40% to 50% of the heavier settle-able 
solids forming primary sludge on the bottom of the settling 
tanks, and lighter materials float to the tanks surface [29]. 
1.2.2.3 Secondary treatment 
The secondary treatment is designed for removal of 
biodegradable dissolved and colloidal organics and suspended 
solids that have escaped the primary treatment by utilizing 
biological treatment process. In the secondary treatment unit, 
three types of technologies can be applied to break down 
organic material with agitation and aeration. There are: 
activated sludge process, trickling filters, and lagoon system 
[30, 32]. Activated sludge process removes the dissolves 
organic material and converts colloidal matter to a biological 
sludge which rapidly settles. The activated sludge process uses 
a variety of mechanisms to utilize dissolved oxygen to 
promote the growth of biological flock that substantially 
breaks down and removes organic material, then allows these 
solids flock to settle out [29, 33-34]. 
1.2.2.4 Tertiary treatment 
Any addition processing after secondary treatment is called 
tertiary treatment which is physical-chemical processes 
applied to remove more suspended solids, organic matter, 
nitrogen, phosphorous, heavy metals and bacteria. These 
processes include, ozonation, photo-catalytic degradation of 
recalcitrant compounds (UV/TiO2, and adsorption) [31, 34-
36]. Tertiary treatment may also involve physical-chemical 
separation techniques such as carbon adsorption, 
flocculation/precipitation, membranes for advanced filtration, 
ion exchange, dechlorination and reverse osmosis [35]. 
1.3 Membrane filtration 
Membrane filtration technology is a separation process, in 
which a semi-permeable membrane acts as a filter that allows 
water flow through, while removing suspended solids and 
other substances [37]. Membrane technology has been used 
for a tertiary wastewater treatment process after secondary 
biological wastewater treatment as an advanced wastewater 
treatment stage. Application of membrane technology to 
wastewater treatment has expanded due to increasingly 
stringent legislation and continuing advancement of 
membrane technology [38]. The semi-permeable membranes 
which act as a filter or barriers used to separate and remove 
constituents from wastewater ranging from large visible 
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particles to molecular and ionic chemical species including 
bacteria, viruses, and other pathogenic microorganisms [30, 
39]. In membrane separation process, the feed water is 
separated into stream that can pass through the membrane 
known as permeate, and a fraction of feed that cannot pass 
through the membrane known as retentate or concentrate [40]. 
The removal of suspended or colloidal particles based on the 
size of membrane pores relative to that of the particulate 
matter, in the applications that require the removal of 
dissolved contaminants, the molecular weight cutoffs 
(MWCO) is considered the main criteria for effective 
separation, because it specifies the maximum molecular 
weight of solute to be rejected, the removal process is in the 
range of 100 to 500 Daltons [37], other parameters such as the 
kind of driving force (pressure, chemical structure and 
composition of membrane, geometry of construction and type 
of feed flow) play a vital role in the membrane filtration 
process [39]. 
 
1.3.1 Membrane modules 
There are four main types of modules: 1) plate 2) frame, 3) 
tubular spiral wound, and 4) hollow fiber [41]. Hollow fiber 
and spiral wound modules constructions involve sealing the 
membrane material into an assembly; these types of modules 
are designed for long-term use (a number of years).These 
modules are used in drinking water treatment and also in 
wastewater treatment [30, 42]. Hollow fiber and spiral wound 
are made from organic material (synthetic polymers i.e. 
polyamide and polysulphone). Hollow fibers is narrow tube 
made of non-cellulosic polymer, in this type a bundles of 
individual fibers are sealed into a hydraulically housing as 
shown in Structure A (Figure 3, appendix A).The fiber usually 
has a small diameter, around 100 µID and ~ 200 µmod. In 
hollow fiber the feed flows into the module, the permeate flow 
into or out of the hollow fiber and is collected, while retentate 
exits the module for further treatment [43-44]. Spiral wound is 
one of the most compact and inexpensive membrane, in this 
type two flat sheet membranes are placed together with their 
active sides facing away from each other. Each flat sheet 
membrane has one active side through which the smaller 
molecules permeate through, a feed spacer which is a mesh 
like material is placed between the two flat sheet membranes. 
The two flat sheet membranes with feed spacer separating 
them are rolled around perforated tube which is called 
collection tube as shown in Structure B (Figure 3, appendix 
A). Membrane filtration can basically be divided into four 
main technologies based on the driving force used for 
filtration: microfiltration (MF), ultrafiltration (UF), 
nanofiltration (NF), and reverse osmosis (RO). Hollow fiber 
and spiral wound are used for microfiltration (MF), 
ultrafiltration and reverse osmosis (RO) as well [45].The 
driving force can be external pressure, electrical potential 
gradient, concentration gradient, or other driving forces. The 
most commonly used membrane system in water and 
wastewater treatment are pressure-driven membrane. 
Microfiltration (MF), ultrafiltration (UF), nanofiltration (NF), 
and reverse osmosis (RO) use the pressure-driven force and 
are classified according to their pore size. Table S2 
(Supplementary Data) shows the separation characteristics for 
various pressures-driven membrane processes [39, 46]. 
 
1.3.2 Microfiltration (MF) and ultrafiltration (UF) 
Microfiltration (MF) and ultrafiltration (UF) are filtration 
processes, that operate on a physical sieving separation 
process [47], in terms of pore size, MF has the largest pore 
size (0.1- 3.0 microns), but UF pore sizes range from 0.01- 0.1 
microns; for that MF is typically used for turbidity reduction, 
removal of suspended solids, giardia and cryptosporidium. On 
the other hand, UF membranes which have smaller pore size 
are used to remove some viruses, color, odor, and some 
colloidal natural organic matter [48]. In addition, both 
processes (MF and UF) require low trans-membrane pressure 
(1 -30 psi) to operate (LPMS), and both are used as 
pretreatment to desalination technologies such as reverse 
osmosis (RO), nano-filtration (NF) and electro-dialysis [48]. 
 
1.3.3 Nanofiltration (NF) and Reverse osmosis (RO) 
Nanofiltration is a medium to high-driven membrane filtration 
process (150 - 1000 Kpa), and has a pore size around 0.001 
micron. Nanofiltration removes most organic molecules, 
nearly all viruses, most of the natural organic matter and some 
salts, where large ionic species, including divalent and 
multivalent ions, and more complex molecules are highly 
retained [30], while allows the diffusion of certain ionic 
solutes, such as sodium and chloride and monovalent ions in 
general. In reverse osmosis (RO) a high-driven pressure 
against a semi-permeable membrane is required (more than 
1000 Kpa), due to the great osmotic difference between the 
solutions on each side of the membrane, which is greater than 
in the nanofiltration case. In terms of pore size RO filters have 
pore size around 0.0001 micron, the molecular weight cutoff 
(MWCO) levels is less than 100 D for RO membranes, and 
between 200 and 1000 D for NF membranes [49-50]. Osmosis 
occurs when a semi-permeable membrane separates two salts 
solutions of different concentrations, the water will migrate 
from dilute solution to a concentrated solution, and this will 
create what is called “osmotic pressure” (Figure 4, appendix 
A). In RO membranes, the force is exercised against the 
osmotic pressure to make the water to move from the more 
concentrated solution to the much diluted one, this will 
increase the volume of water with lower concentration of 
dissolved solid (Figure 4, appendix A)[30, 45]. 
1.4 Occurrence of Pharmaceuticals and personal care 
products (PPCPs) in wastewater 
At present, there is an increasing concern on the presence of 
pharmaceuticals in the environment, the occurrence of drugs 
and their metabolites, and also personal care products (PPCPs) 
in our water became important issue, due to their potential risk 
to the aquatic environment. Thousands of tons of 
pharmaceuticals are used yearly with different purposes, such 
as prevention, diagnosis, care, and mitigation of diseases or to 
improve the state of health. The same quantity or more 
consumed from PPCPs which include analgesics, fragrances, 
sun screen shampoos and cosmetics. All these pharmaceuticals 
and PPCPs can end up in the aquatic environment, where the 
discharge of therapeutic agents from production facilities, 
hospitals and private household effluent, as well as improper 
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disposal of unused drugs pose a burden on the environment 
[51-53]. The fate of these pharmaceuticals and PPCPs will be 
in the wastewater treatment plants (WWTPs), where the 
conventional wastewater treatment in WWTPs are based on 
primary, secondary and tertiary treatment in some cases, but 
these conventional treatments are not specifically designed to 
remove pharmaceuticals [51]. Therefore, effluents from 
wastewater treatment plants (WWTPs) can be considered as 
one of the most important sources of pharmaceuticals in 
aquatic environment, since these compounds are not fully 
eliminated during the conventional treatment process, and they 
are only partially eliminated [54]. 
1.4.1 Analytical methods 
A number of studies indicated the presence of pharmaceuticals 
and personal care products (PPCPs) traces in the aquatic 
environmental at different concentrations. For example, a 
study carried out in Australia, Brazil, Canada, Croatia, 
England, Germany, Greece, Italy, and USA detected more 
than 80 pharmaceuticals and their corresponding metabolites 
in the aquatic environment at concentrations in the µgL
-1
 range 
or lower [76]. Another study performed in Spain reported the 
presence of 13 pharmaceuticals and personal care products 
(PPCPs) in municipal wastewater, eight compounds were 
detected in raw wastewater in the range of 0.6 – 6.6 µgL-1 
[55]. Another reported study demonstrated that 27 of 32 
pharmaceuticals and four metabolites were detected in 
European municipal wastewater treatment plant effluents at 
values of over 1 µgL
-1
 [75]. Generally, it was reported that 
drug residue concentrations found in receiving water fall in the 
low ngL
-1
 to low µgL
-1
[61]. 
The presence of pharmaceuticals and personal care products 
(PPCPs) at trace levels (ngL
-1
) and in complex water matrices, 
such as wastewater and surface water, makes their analysis 
difficult [56]. Currently, no standardized analytical methods 
are available for the analysis of pharmaceuticals and organic 
micropollutants in the environmental waters, because these 
pharmaceuticals represent structurally diverse classes of 
compounds, and owing to the diversity of physic-chemical 
properties. Hence, different analytical methods have been used 
for the identification and quantification of these chemicals in 
water samples [57]. The most common sample isolation and 
pre-concentration technique is solid phase extraction (SPE) 
[53]. SPE also is used for cleanup of pharmaceuticals in water 
samples [58]. Variations of SPE include solid phase micro-
extraction (SPME) and various on-line and automated SPE 
techniques [59].  
1.4.2 Method of treatment 
Even that pharmaceuticals residue and their metabolites are 
usually detectable in the environment at trace levels, the low 
concentration level (ngL
-1
 - µgL
-1
) can induce toxic effects, as 
in the cases of antibiotic and steroids that cause resistance in 
natural bacterial populations or endocrine disruption effects 
[60]. Pharmaceuticals are designed to interact with receptors 
in humans and animals, but in aquatic environment the 
organisms exhibiting the same enzyme receptors as humans 
and therefore they could experience similar pharmacodynamic 
effects [61]. Although concentrations of many 
pharmaceuticals residues in potable drinking water are so low 
and do not pose high risks to human beings, the main concern 
is the chronic and/or synergistic effects of the “cocktail” of 
pharmaceuticals that human have released to water body [62-
63]. 
The methods of treatment used for the removal of 
pharmaceuticals from wastewater are the following: (1) 
biodegradation, (2) deconjugation, (3) partitioning, (4) 
removing during sludge treatment and (5) photodegradation 
[64]. 
(1) Biodegradation: biological degradation can take place in 
wastewater by means of aerobic/anaerobic microbial 
degradation of the drug substance leading to reduction of 
parent compounds and/or their metabolites during wastewater 
treatment [64]. The microbes include bacteria, yeasts, fungi, 
protozoa, and unicellular plants and rotifers, some of these 
organisms have the ability to degrade some of most hazards 
and recalcitrant chemicals [65]. 
(2) Deconjugation: pharmaceuticals compounds are often 
metabolized in the liver, and as a consequence glucuronide 
and sulfate conjugates of the parent drug are excreted. 
Deconjugation of organic compounds such as steroid 
hormones in domestic wastewater and within sewage 
treatment plans (STPs) occur due to the large amounts of β-
glucosidase enzyme present. 
(3) Partitioning: partitioning between the aqueous and organic 
biomass phase is considered the key component in 
determining the ultimate concentration of organic pollutants. 
Compounds with high log Ko/w (lipophilic molecules) values 
are known to sorb to sludge, while substances with lower 
values are more likely to stay in the aquatic phase, depending 
on the individual compound, and substances sorbing to solids 
may also be remobilized if they are not strongly bound [64]. 
(4) Removal during sludge treatment: drugs may also be 
degraded by a biotic process (hydrolysis and oxidation) during 
sewage treatment process. Many pharmaceuticals are not 
thermally stable, and might be expected to break down during 
processes such as compositing due to heat as well as chemical 
and biodegradation processes [64]. 
(5) Photodegradation: several pharmaceuticals have proven to 
degrade due to the action of sunlight. Some pharmaceuticals 
such as diclofenac which is analgesic/anti-inflammatory drug, 
has been shown to degrade in aquatic environment due to 
ultraviolet (UV) light [64]. Due to incomplete elimination in 
wastewater treatment plants (WWTPs) using the conventional 
treatment method, residues of pharmaceuticals and PPCPs are 
found in both wastewater and surface water [66].Therefore, an 
improvement of this situation requires the application of 
advanced treatment techniques, such as membrane filtration 
technology, nanofiltration and reverse osmosis [67, 72-74], 
advanced oxidation processes [68], and activated carbon 
adsorption [64, 67, 72-74]. 
This study reports the efficiency of advanced technology for 
the removal of selected pharmaceuticals, ibuprofen and 
mefenamic acid, at the wastewater treatment plant at Al-Quds 
University which includes ultrafiltration (hollow fiber and 
spiral wound), activated carbon and reverse osmosis. In 
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addition, the adsorption of both pharmaceuticals using 
ODTMA-clay-micelles complex is reported. 
2. Experimental 
2.1. Instrumentation 
2.1.1. High Performance Liquid Chromatography 
High Performance Liquid Chromatography (HPLC-PDA) 
system consists of an alliance 2695 HPLC (Waters: Milford, 
MA, USA), and a waters Micromass® Masslynx™ detector 
with Photo diode array (Waters 2996: Milford, MA, USA). 
Data acquisition and control were carried out using Empower 
™ software (Waters: Milford, MA, USA). Analytes were 
separated on a 4.6 mm ×150 mm C18 XBridge® column (5 
μm particle size) used in conjunction with a 4.6 mm × 20 μm 
XBridge™ C18 guard column. Microfilter was used with 0.45 
μm (Acrodisc® GHP, Waters). 
2.1.2 pH meter 
pH meter model HM-30G: TOA electronics™ was used in this 
study to measure the pH values for the samples 
2.1.3 Centrifuge and Shaker 
Labofuge®200 Centrifuge was used, 230 V 50/60 Hz. CAT. 
No. 284811 (Germany). Some of pharmaceuticals solutions 
were shaken with an electronic shaker (Bigbill shaker, Model 
No.: M49120-26, 220-240 V 50\60 Hz.) at 250 rpm. 
 
2.1.4 Description of Wastewater Treatment Plant (WWTP) 
The wastewater treatment plant (WWTP) at Al-Quds 
University collects a mixture of black, gray, and storm water. 
The treatment plant consists of a primary treatment (two stage 
primary settling basin), and a secondary (activated sludge with 
a hydraulic retention time of 16-20 hours, coagulation and 
chlorination) treatment. Then, the secondary effluent is 
introduced to the sand filter before entering the ultra- filtration 
membrane (Hollow fiber and Spiral wound). After the ultra-
filtration process, the effluent is subjected to activated carbon 
column followed by a reverse osmosis (advanced treatment). 
Then, a blend of all effluents is used for irrigation. The ultra-
filtration process is made of two small scale membranes with a 
capacity of 12 m
3
 /day. The first UF unit is equipped with 2 x 
4 inch pressure vessels with pressure resistance up to 150 psi. 
Each vessel holds two separation membranes (spiral wound 
with 20 kD cutoffs which is equivalent to 0.01 micron 
separation rate). The designed permeate capacity of the system 
is 0.5-0.8 m
3
/h. This membrane can remove bacteria, 
suspended solids, turbidity agents, oil, and emulsions. The 
second unit is equipped with two pressure vessels made from 
Vendor (AST technologies, model number 8000 WW 1000-
2M) that houses the hollow fiber membranes with 100 kD 
cutoff (Vendor, AST technologies, Model no. 8000- 
WWOUT-IN-8080). The two units are designed to deliver 
1.5m
3
/h. The reverse osmosis (RO) membrane is made from 
thin film polyamide which consists of 1 x 4 inch pressure 
vessel made from composite material with pressure resistance 
up to 400 psi. The vessel holds two 4 inches special separation 
membranes (manufactured in thin film polyamide with pH 
range 1-11 models BW30-4040 by DOW Film Tec.). 
Membranes anti-scalent (Product NCS-106-FG, made of 
phosphate in water with active ingredient of phosphonic acid 
disodium salt) are continuously dosed to the RO feed at 
concentration of 4 ppm in order to prevent deposition of 
divalent ions. The system is designed to remove major ions 
and heavy metals. The designed RO permeate capacity of the 
system is 0.45- 0.5 m
3
/h. 
2.2. Chemicals and Reagents 
Pure standards of ibuprofen (> 99%), mefenamic acid (> 99%) 
were obtained from local pharmaceutical company. 
Acetonitrile, methanol HPLC grade, orthophosphoric acid, 
magnesium sulfate, Charcoal activated fine powder with 
particle size (≤ 60.0 micron), charcoal activated granules with 
particle size (≤ 700.0 micron), and 
octadecyltrimethylammonium (ODTMA) complex were 
purchased from Sigma chemical company, C18 (1 g) cartridges 
6cc single use for general laboratory use were purchased form 
Waters company (Milford, MA, USA).   
2.3. Methods (Ibuprofen and mefenamic acid) 
2.3.1. Calibration curves using the solid phase cartridge 
The C18 cartridges were preconditioned by passing first 10 mL 
of water through the cartridge and then 10 mL of acetonitrile. 
The cartridges were then air dried. Several solutions of 
ibuprofen and mefenamic acid with different concentrations 
(1.0, 5.0, 10.0, 20.0, 30.0, 40.0, and 50.0 ppm) were prepared. 
10 mL of each of these solutions was passed through the 
cartridge. The adsorbed mefenamic acid or ibuprofen was 
eluted from the adsorbent of the cartridge using 10 mL of 
acetonitrile. Afterwards, 20 µl of the eluate was injected into 
the HPLC and analyzed using the HPLC conditions for 
ibuprofen and mefenamic acid. Peak areas vs. concentration of 
ibuprofen and mefenamic acid was then plotted, and 
correlation coefficient of the plots were recorded.  
2.3.2 Stability study of ibuprofen and mefenamic acid 
2.3.2.1. Stability study in pure water 
For this study, a 50 ppm solution of ibuprofen (prepared by 
dissolving ibuprofen in distilled water adjusted to pH 8.0 by 
using 1N sodium hydroxide) was used. Samples at specific 
time intervals (0, 1, 2, 4, 5, 10, 15, 20, 25, 30 days) were 
taken, and analyzed by HPLC method for ibuprofen. The 
concentration of ibuprofen at each time interval was calculated 
from a calibration curve and compared to the original 
concentration (50 ppm), and then the percentage of ibuprofen 
degraded was calculated. The same procedure was applied for 
mefenamic acid; HPLC method for mefenamic acid was used.  
2.3.2.2 Stability study in the presence of sludge 
The same procedure described in section (2.3.2.1) was applied 
for studying the stability of ibuprofen and mefenamic acid in 
the presence of sludge but water was replaced with a 
suspended sludge in plain water. In this experiment aeration 
was performed to maintain the bacterial growth within the 
sample during the whole study period.  
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2.3.3 Micelle-clay complex preparation 
The micelle–clay complex was prepared by stirring 12mM of 
ODTMA with 10g/L clay for 72 hours. Suspensions were 
centrifuged for 20 min at 15 000 g, supernatants were 
discarded, and the complex was lyophilized.  
2.3.4 Calibration curves 
(a) Stock solution: Stock solution was prepared by 
dissolving ibuprofen and mefenamic acid standards in water 
that adjusted to pH 8.0 to a concentration of 1000 ppm for the 
use in (b). 
(b) Calibration curves: The following diluted solutions were 
prepared from the stock solution of ibuprofen (1.0, 5.0, 10.0, 
25.0, 50.0, 100, 200, 500 and 1000.0 ppm). 20 µl of each 
solution was injected into the HPLC and the peaks for 
ibuprofen were recorded using the following HPLC 
conditions: C18 column, wavelength = 220 nm, Flow rate = 
2.0 mL/min, mobile phase: 50 % of 0.07 % phosphoric acid 
solution/ 50 % acetonitrile. For mefenamic acid, the same 
procedure was followed but using the following HPLC 
conditions: C18 column, wavelength = 350 nm, flow rate = 1.0 
mL/min. Peak areas vs. concentration of ibuprofen and 
mefenamic acid (in ppm) was then plotted, and R
2 
of the plots 
are recorded.  
2.3.5 Batch adsorption isotherms 
Equilibrium relationships between adsorbents (clay micelle 
complex and activated charcoal) and adsorbate (ibuprofen and 
mefenamic acid) are described by adsorption isotherms. This 
was done by studying the percentage removal of the adsorbate 
by both adsorbents (clay micelle complex and activated 
charcoal) at different concentrations (50, 100, 200, 500 and 
1000 ppm) prepared in distilled water at pH = 8.0 adjusted by 
using 1M sodium hydroxide. The following procedure was 
applied: 100 mL from each solution was transferred to 200 mL 
Erlenmeyer flask, 0.5 g of the clay micelle complex was then 
added to the flask. Then the flask was placed on a shaker for 
180 minutes. Afterwards, each sample was centrifuged for 5 
minutes, and filtered using 0.45 µm filter. Then 20 µl of the 
filtered solution was injected into the HPLC and the peak 
areas of ibuprofen and mefenamic acid were recorded. 
2.3.6 Efficiency of the wastewater treatment plant 
(WWTP) of Al-Quds University for removal of ibuprofen 
and mefenamic acid 
The efficiency of different membranes (hollow fiber (HF-UF), 
spiral wound (SW-UF), activated carbon and reverse osmosis 
(RO) membranes) for the removal of ibuprofen from 
wastewater was studied by spiking ibuprofen in the storage 
tank of the wastewater treatment plant at a concentration of 40 
ppm (by dissolving 25 g of ibuprofen in the storage tank 
containing 625 liters of activated sludge wastewater). Samples 
were taken from the following points of the WWTP: (1) 
storage tank (before running wastewater treatment plant) (2), 
(3), and (4) feed-, brine- and product-points of the HF-UF 
membrane, respectively (5) and (6) concentrated -, and 
permeated-UF point of the HF- SW membrane, respectively 
(7) activated carbon point, and (8) reverse osmosis point. 
These sampling points are shown in (Figure 5, appendix A). 
These samples were treated using SPE C18 cartridge as 
follows: 10 mL of sample was loaded into the C18 cartridge, 
and allowed to pass through the cartridge by effect of gravity. 
Ibuprofen adsorbed on the C18 cartridge was then eluted using 
10 mL of acetonitrile. 20 µl of the eluted solution was injected 
into the HPLC, and analyzed using the HPLC conditions for 
ibuprofen method of analysis. The concentration of ibuprofen 
in each sample was calculated using the calibration curve for 
ibuprofen (see section 2.3.1). The same procedure was applied 
to study the efficiency of the WWTP for the removal of 
mefenamic acid where 40 ppm of mefenamic acid was spiked 
into the storage tank (by dissolving 25 g mefenamic acid in the 
storage tank containing 625 liters of activated sludge 
wastewater). Sampling procedure and treatment of the samples 
by SPE cartridges was followed as described for ibuprofen. 
The procedure for the calculation of the concentration of 
mefenamic acid in the tested samples was followed as 
described for ibuprofen, but using the HPLC conditions and 
calibration curve for mefenamic acid. 
3. Results and discussion 
3.1. Ibuprofen 
Ibuprofen is a stable white crystalline powder and is only very 
slightly soluble in water. Less than 1 mg of ibuprofen 
dissolves in 1 mL water (< 1 mg/ mL). It is soluble in organic 
solvents like acetonitrile and alcohols. Ibuprofen is a member 
of the class of agents commonly known as nonsteroidal anti-
inflammatory drugs (NSAIDs). It is used to relief the 
symptoms of a wide range of illnesses such as headaches, 
backache, period pain, dental pain, neuralgia, rheumatic pain, 
muscular pain, migraine, cold and flu symptoms and arthritis. 
Ibuprofen is an over the counter drug (OTC) and is consumed 
with large quantities daily [69]. 
3.1.1 Calibration curve for ibuprofen using solid phase 
extraction cartridge (SPE) 
The calibration curve was obtained by plotting peak area 
versus concentration (in ppm) and is displayed in (Figure 6, 
appendix A) (seven data points) in the range 1.0 ppm – 50 
ppm) of ibuprofen. The plot shows excellent linearity with 
correlation coefficient (R
2
) of 0.99.  
3.1.2 Stability study of ibuprofen 
3.1.2.1. Stability of ibuprofen in pure water 
Stability study of ibuprofen in pure water has carried out with 
ibuprofen concentration of 50 ppm in pure water and at 25 C° 
for 30 days. Samples were taken at different time intervals (0, 
1, 2, 4, 5, 10, 15, 20, 25, and 30 days). The kinetic results 
showed that ibuprofen was stable at these conditions and no 
degradation products of the drug was detected (Figures 7 and 
8, appendix A). 
3.1.2.2 Stability study in the presence of sludge 
Stability studies of ibuprofen was also conducted (as in section 
3.1.2.1) in wastewater containing sludge with total plate count 
(TPC) = 25 X10
7 
cfu/100 mL at 25 C° for 30 days. The results 
revealed that ibuprofen was stable in this media, and no 
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ibuprofen degradation products was observed (Figures 9 and 
10, appendix A). 
 
3.1.3 HPLC conditions for analysis of ibuprofen 
C18 column, wavelength = 220 nm, Flow rate = 2.0 mL/min, 
mobile phase: 50 % of 0.07 % phosphoric acid solution/50% 
acetonitrile. 
3.1.4 Adsorption studies of ibuprofen on a clay micelle 
complex (ODTMA) and activated charcoal 
The adsorption mechanism depends on the physicochemical 
properties of the pharmaceutical and the aquifer media 
properties. Adsorption of ibuprofen onto a clay micelle 
complex and charcoal adsorbents was investigated and 
described in the following sections. 
 
3.1.4.1 Adsorption of ibuprofen on the clay micelle 
complex (ODTMA) 
The clay micelle complex (ODTMA) is prepared by mixing 
certain type of clay mineral (montmorillonite) with cationic 
surfactant. In this study octadecyltrimethylammonium 
(ODTMA), (Structure 3 in Figure 2, appendix A) with a 
critical micelle concentration (CMC) value of 0.3 mM was 
employed for the complex formation. A certain mass of clay 
was introduced into a solution of ODTMA until reaching a 
concentration of 1 × 10
-2
 M then stirred for 24 hours at 37 ˚C. 
The complex was filtered, dried and mixed with excess sand. 
This complex by virtue of its positive charge with 
hydrophobic region is capable of binding negatively charged 
organic molecules [70]. 
3.1.4.1.1 Adsorption of ibuprofen on (ODTMA) at pH 4.0 
The efficiency of octadecyltrimethylammonium (ODTMA) 
complex for a removal of ibuprofen form a spiked sample was 
studied by preparing a solution of ibuprofen with 200 ppm 
concentration by dissolving ibuprofen in distilled water at pH 
= 4.0 adjusted by using 1M sodium hydroxide. A 100 mL 
from this solution was then transferred to 200 mL Erlenmeyer 
flask, 0.5 g of the complex was added to the Erlenmeyer flask 
containing the sample of ibuprofen, and then the Erlenmeyer 
flask was shacked for 180 minutes. Samples were taken 
according to determined intervals. Each sample was 
centrifuged for 5 minutes, and then it was filtered through 0.45 
µ Millipore filter. Then 20 µl of each solution was injected 
into the HPLC and the peaks were recorded using the same 
HPLC conditions used in section 3.1.3. Table S3 
(Supplementary Data) and (Figure 10, appendix A) showed 
incomplete removal of ibuprofen. The pKa of ibuprofen is 4.4 
and the pH of the spiked samples is 4.0. Therefore at pH 4 a 
solution of ibuprofen will exist approximately 50% in the 
ionized and 50% in the non-ionized forms. Results have 
shown that the percentage removal of ibuprofen in spiked 
samples at pH 4.0 was about 59.0%. This percentage of 
removal might be attributed to the interaction between the 
ionized forms of ibuprofen with the positively charged clay 
micelle complex. At pH 4, ibuprofen is 50% negatively 
charged and 50 % uncharged, so only the negative form of 
ibuprofen interacts with the positively charged complex 
indicating that the type of interaction between ibuprofen and 
the complex is electrostatic, while the hydrophobic interaction 
is negligible. It is worth noting that the removal of ibuprofen 
is relatively fast: about 59% in 5 minutes, however after this 
period the percentage removal remains constant up to three 
hours. 
3.1.4.1.2 Adsorption of ibuprofen on (ODTMA) at pH 8.0 
The percentage removal of ibuprofen by a clay micelle 
complex was also studied at pH 8.0.The same procedure was 
applied as in section 3.1.4.1.1, by preparing a solution of 
ibuprofen at a concentration of 200 ppm in distilled water at 
pH = 8.0 adjusted by 1M sodium hydroxide, where ibuprofen 
at pH 8.0 completely exists in the ionized form. Results have 
shown that ibuprofen is 90 % removed at pH 8.0. Table S4 
(Supplementary Data) and (Figure 12, appendix A) 
demonstrated that the mode of interaction between ibuprofen 
and the clay micelle complex is mainly electrostatic, and the 
hydrophobic interactions are scarily involved. It is worth 
noting that about 84.0% of ibuprofen is eliminated in the first 
5 minutes, and only 6.5% of ibuprofen was removed during 
the remaining time (about three hours).This indicates that the 
removal process by the clay micelle complex (ODTMA) is 
very fast.   
3.1.4.2 Adsorption of ibuprofen on the activated charcoal 
The efficiency of activated charcoal for the removal of 
ibuprofen form a spiked sample was studied by preparing 200 
ppm concentration of ibuprofen in distilled water at pH = 8.0 
adjusted by using 1M sodium hydroxide, then 100 mL from 
this solution was transferred to 200 mL Erlenmeyer flask, 0.5 
g of the activated charcoal was added to an Erlenmeyer flask 
containing the sample of ibuprofen, then the Erlenmeyer flask 
was put on a shaker for 180 minutes. Samples were taken 
according to determined intervals. Each sample was 
centrifuged for 5 minutes, and then was filtered by 0.45 µ 
Millipore filter. 20 µl of each solution was injected into the 
HPLC and the peaks were recorded using the same HPLC 
conditions used in previous sections. Table S5 (Supplementary 
Data) and (Figure 13, appendix A) illustrate the removal of 
ibuprofen by activated charcoal. The results revealed that 
activated charcoal is effective for the removal of ibuprofen 
from spiked samples (200 ppm) at pH = 8.0. The removal was 
about 98% and achieved after two hours. The capacity of the 
clay micelle complex and activated charcoal towards 
adsorption of ibuprofen was quite comparable. The results 
demonstrated that the adsorption of ibuprofen on a clay 
micelle complex is faster when compared to that with the 
activated charcoal (about 84% of ibuprofen was removed in 
the first 5 minutes while only 49% of ibuprofen was removed 
by the activated charcoal). However, after three hours the 
adsorption capacity of the clay complex and activated charcoal 
was about similar (90% for the clay complex and 99% for 
activated charcoal).    
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3.1.4.3 Analysis of adsorption isotherms 
Equilibrium relationships between adsorbents (clay micelle 
complex and charcoal) and adsorbate (i.e. ibuprofen) are 
described by adsorption isotherms. The most common model 
for adsorption process is a Langmuir adsorption isotherm 
which is considered as the most widely used modeling for 
equilibrium data and determination of the adsorption capacity 
[71]. It is a linear form and represented by the following 
equation: 
Ce/Qe = 1/ (K Qmax) + Ce/Qmax……… Eq. (1) 
Where:  
Ce: equilibrium concentration of ibuprofen (mg/L). 
Qe: the equilibrium mass of the adsorbed ibuprofen per gram 
of complex (mg.g 
-1
) 
 (mg.g 
-1
). 
K:Langmuir constant  
 
Qmax: maximum mass of Ibuprofen removed per gram of 
complex (mg.g 
-1
) 
For this study the adsorption of ibuprofen of five 
concentrations (50, 100, 200, 500, and 1000 ppm) on the clay 
micelle complex and activated charcoal were studied, then Ce, 
and Qe were calculated as in Tables S6 and S7 (Supplementary 
Data). Ce/Qe vs. Ce was plotted for ibuprofen adsorbed onto 
both clay micelle complex and activated charcoal (Figure14, 
appendix A).  
The two parameters Qmax and K values for the adsorption of 
ibuprofen on the clay micelle complex and activated charcoal 
can be calculated from the slopes and y-intercepts of the 
equations obtained from the plots (Qmax = slope
-1
, K = (y-
intercept)
-1
(Qmax)
-1
). Table 1 (appendix B) shows the values 
for Qmax and k for ibuprofen adsorbed on both clay micelle 
complex and activated charcoal. Qmax and K parameters for 
the removal of Ibuprofen by the clay micelle complex were 
calculated as follows: 
Slope = 1/ Qmax =0.016;Qmax = 62.5 mg/g  Eq. (2) 
 
Intercept = (1/ K x Qmax) = 0.025; K = 0.64Eq.(3) 
The same procedure was applied for calculation of the Qmax 
and K for removal of ibuprofen by the activated charcoal. The 
results demonstrated that both adsorbents, the clay micelle 
complex and activated charcoal, have the same efficiency for 
the removal of ibuprofen as both Qmax are comparable (62.5 
mg of ibuprofen per gram of complex, and 66.7 mg of 
ibuprofen per gram of activated charcoal) , As shown in 
(Figure 14, appendix A) the relationship between Ce/Qe and Ce 
is linear for both the clay micelle complex and activated 
charcoal with R
2
 greater than 0.99 which indicates that the 
adsorption of ibuprofen onto clay micelle and charcoal follows 
the Langmuir isotherm model. 
3.1.5 Efficiency of the wastewater treatment plant 
(WWTP) at Al-Quds University for the removal of 
ibuprofen 
The efficiency of the wastewater treatment plant (WWTP) at 
Al-Quds University for ibuprofen removal was studied. Result 
demonstrated that ibuprofen was 59.8% removed at hollow 
fiber stage (UF-HF), while about 94.7% of ibuprofen was 
removed at spiral wound (SW) stage, (Tables S8 and 
S9)(Supplementary Data). At the activated carbon adsorbent 
point of the wastewater treatment plant, 98.8% of ibuprofen 
was removed. The results also indicate that complete removal 
(99.9%) of ibuprofen was achieved after passing through the 
reverse osmosis membrane , RO (Figures 15, 16 , 17 and 18). 
These findings demonstrate that the WWTP at Al-Quds 
University is effective for the removal of ibuprofen. UF-HF 
and UF-SW are responsible for 60% and 95% removal, 
respectively, while activated carbon and RO are responsible 
for 99% and 99.9%, respectively. Hence, activated carbon and 
RO system are crucial components for the removal of 
ibuprofen such that the environmental acceptable standards 
could be reached.  
3.2 Mefenamic acid 
Mefenamic acid is a non-steroidal anti-inflammatory drug 
(NSAIDs), used to treat pain; it is typically prescribed for oral 
administration. Mefenamic acid decreases inflammation 
(swelling) and uterine contractions, and is consumed with 
large quantities every day, and used in large quantities 
throughout Palestine [69]. 
3.2.1 Calibration curve for mefenamic acid using solid 
phase extraction cartridge (SPE) 
The calibration curve was obtained by plotting peak area 
versus concentration (in ppm) and is displayed in (Figure 
18, appendix A) (seven data points) in the range 1.0 ppm – 
50 ppm for mefenamic acid. The plot shows excellent 
linearity with correlation coefficient (R
2
) of 0.99.  
3.2.2 Stability study of mefenamic acid 
3.2.2.1. Stability of mefenamic acid in pure water 
Stability study of mefenamic acid in pure water has carried out 
where the concentration of mefenamic acid in pure water was 
50 ppm and the temperature of the solution was kept at 25 °C 
for 30 days. Samples were taken at different time intervals (0, 
1, 2, 4, 5, 10, 15, 20, 25 and 30 days). The kinetic results 
showed that mefenamic acid was stable at these conditions and 
no degradation products was detected as shown in Figures 20 
and 21 (appendix A). 
 
3.2.2.2 Stability study in the presence of sludge 
Stability studies of mefenamic acid was also conducted (as in 
section 3.2.2.1) in wastewater containing sludge with total 
plate count (TPC) = 25 X 10
7 
cfu/100 mL at 25 °C for 30 days. 
The results revealed that mefenamic acid was also stable in 
this media, and no degradation products was observed as 
shown in Figures S1 and S2 (Supplementary Data) . 
 
3.2.2.3 Calibration curve 
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The calibration curve was obtained by plotting peak area 
versus concentration and is displayed in (Figure 22, appendix 
A) (eleven data points) for mefenamic acid. The figure shows 
excellent linearity in the range (0.8 -1000.0 ppm) with 
correlation coefficient (R
2
) of 1.0. 
 
3.2.3 Adsorption studies of mefenamic acid on the clay 
micelle complex (ODTMA) and activated charcoal 
Adsorption of mefenamic acid onto a clay micelle complex 
and charcoal adsorbents was investigated in the same manner 
to that of ibuprofen. 
3.2.3.1 Adsorption of mefenamic acid on the clay micelle 
complex (ODTMA) 
The efficiency of octadecyltrimethylammonium (ODTMA) 
complex for the removal of mefenamic acid form a spiked 
sample was studied by preparing a solution of mefenamic acid 
with a concentration of 200 ppm, prepared by dissolving 
mefenamic acid  in distilled water at pH = 8.0 adjusted by 
using 1M sodium hydroxide, then (as in ibuprofen) 100 mL 
from this solution was transferred to 200 mL flask, 0.5 g of the 
complex was added to the Erlenmeyer flask containing the 
sample of mefenamic acid, then the flask was shaken for 180 
minutes. Samples were taken according to determined 
intervals. Each sample was centrifuged for 5 minutes, and then 
was filtered by 0.45 µ Millipore filter. 20 µl of each solution 
was injected into the HPLC and the peaks were recorded using 
the same HPLC conditions for mefenamic acid used in the 
previous sections. Table S10 (Supplementary Data) and 
(Figure 23, appendix A) indicate complete removal for 
mefenamic acid by ODTMA complex. The results of this 
study revealed that only 5 minutes were needed for a complete 
removal of mefenamic acid (97.3% removal). Similarly to 
ibuprofen, the results of mefenamic acid showed that 
electrostatic interaction between mefenamic acid and the clay 
micelle complex is the predominate mode of interaction rather 
than hydrophobic interaction. Comparison of the removal of 
mefenamic acid and ibuprofen on the clay micelle complex 
demonstrated that the removal of mefenamic acid is faster and 
more efficient than that of ibuprofen.  
3.2.3.2 Adsorption of mefenamic acid on activated 
charcoal 
The capacity of activated charcoal for adsorption of 
mefenamic acid was studied, in the same manner as that for 
ibuprofen (section 3.1.4.2).The results demonstrated that 
activated charcoal is quite effective in removing mefenamic 
acid from spiked samples of (200 ppm) (97.2 % removal after 
3 hours) (Table S11, Supplementary Data and Figure 24, 
appendix A). The combined results revealed that the capacity 
of the clay micelle complex and activated charcoal for 
mefenamic acid removal was quite comparable. In addition, 
the results demonstrated that the adsorption of mefenamic acid 
on a clay micelle complex is very fast compared to that of 
mefenamic acid on activated charcoal, 96 % of mefenamic 
acid was removed in the first 5 minutes by a clay complex vs. 
only 28 % by activated charcoal. Furthermore, the adsorption 
of mefenamic acid on a clay micelle complex was faster than 
that of ibuprofen (96% vs. 84% in the first 5 minutes). It 
should be indicated that the adsorption mode of these two 
pharmaceuticals on activated charcoal is somewhat different. 
The percentage of the removal for mefenamic acid in the first 
5 minutes by activated charcoal was only 28 % whereas that of 
ibuprofen was 49.6%. However, after 3 hours, the adsorption 
capacity of the clay complex and activated charcoal was 
almost similar (97.3% when using clay micelle complex and 
97.2 % when using activated charcoal).    
3.2.4 Analysis of adsorption isotherms 
As for ibuprofen (section 3.1.4.3) the adsorption of mefenamic 
acid in different concentrations (50, 100, 200, 500, and 1000 
ppm) on the clay micelle complex and activated charcoal was 
studied. The Ce, and Qe were calculated, then Ce/Qe was 
plotted against Ce and the linear relationships obtained are 
illustrated in (Figure 25, appendix A). As shown in (Figure 25, 
appendix A), the relationship between Ce/Qe and Ce is linear 
for both the clay micelle complex and activated charcoal with 
R
2
 greater than 0.99. The two parameters Qmax and K values 
for the adsorption of mefenamic acid on a clay micelle 
complex and activated charcoal was calculated from the slops 
and y-intercepts of the equations obtained from the plots (Qmax 
= slop
-1
, K = (y-intercept)
-1
(Qmax)
-1
). Table 2 (appendix B) 
shows the values for Qmax and K for mefenamic acid adsorbed 
on both clay micelle complex and activated charcoal. Qmax 
and K parameters for the removal of mefenamic acid by the 
clay micelle complex were calculated as follows: 
Slope = 1/ Qmax = 0.010; Qmax = 100 mg/g …..Eq. (4) 
Intercept = (1/ K x Qmax) = 0.095; K = 0.105 L/mg … Eq. (5) 
The same procedure was applied for the calculation of Qmax 
and K for removal of mefenamic acid by the activated 
charcoal (Tables S12 and S13, Supplementary Data). The 
combined results demonstrated that both adsorbents, clay 
micelle complex and activated charcoal were quit efficient in 
the removal of mefenamic acid with both having close Qmax 
values (100 mg of mefenamic per gram of complex vs. 91 mg 
of mefenamic acid per gram of activated charcoal). It is 
noteworthy here to compare the efficiency of both adsorbents 
for removal of ibuprofen and mefenamic acid by comparing 
Qmax values. It is clear from these values Table S14 
(Supplementary Data) that both adsorbents have higher 
efficiency for removal of mefenamic acid compared to 
ibuprofen. 
3.2.5 Efficiency of the WWTP at Al-Quds University for 
removal of mefenamic acid 
The efficiency of the wastewater treatment plant at Al-Quds 
University for a removal of mefenamic acid was studied in the 
same manner as described for ibuprofen, where mefenamic 
acid was spiked in a concentration of 40 ppm, and the 
experiment was repeated three times for the repeatability of 
the results. Samples were taken from the same locations as 
described in section 3.1.5. The samples results taken from 
hollow fiber points (UF-HF), demonstrated that mefenamic 
acid was approximately 74.0% removed at this stage, while 
about 94.3% of mefenamic acid was removed after passing the 
spiral wound (SW) stage (Tables S15 and S16) 
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(Supplementary Data). The sample taken after passing 
activated carbon adsorbent point showed that mefenamic acid 
is almost completely removed (98.8%). Finally analysis of the 
samples taken after passing the RO membrane stage which 
includes brine RO and permeated RO indicated that 
approximately complete removal of mefenamic acid was 
achieved in this stage (99.5%) (Figures 26-29, appendix A). It 
is interesting here to compare the efficiency of the WWTP at 
Al-Quds University for the removal of ibuprofen and 
mefenamic acid. Referring to (Tables S9 and S16) 
(Supplementary Data), it is clear that ultrafiltration points of 
the WWTP are not sufficient for complete removal of 
ibuprofen and mefenamic acid; however activated carbon and 
RO are crucial for a complete removal of ibuprofen and 
mefenamic acid. Therefore, it is safe to conclude that the RO 
membrane of the wastewater treatment plant is required for the 
removal of ibuprofen and mefenamic acid to reach the 
acceptable environmental standards.         
4. Summary and Conclusions  
In this study, two acidic pharmaceuticals, ibuprofen and 
mefenamic acid were found to be stable in wastewater (for 30 
days).Therefore, it is necessary to find a method for the 
removal of these pharmaceuticals from wastewater. Advanced 
wastewater treatment plant utilizing ultra filtration, activated 
carbon and RO showed that UF_HF and UF_SW are not 
efficient in removing both drugs to safe level. Whereas 
activated carbon and RO are efficient.  Adsorption studies on 
clay- micelle complex (ODTMA) and charcoal revealed that 
both adsorbents are efficient in the removal of ibuprofen and 
mefenamic acid at pH 8.  The removal efficiency for ibuprofen 
are 90.3% and 99.1%, respectively, whereas the removal 
efficiency for mefenamic acid are 97.3% and 97.2%, 
respectively. These results indicate that an integration of clay-
micelle complex filters within the existing advanced 
membrane treatment system is very promising in improving 
removal efficiency and minimizing cost of treatment
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Appendix A 
 
 Fig. 1. Water consumption in Palestine [5]. 
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Fig. 2. Chemical structures for Ibuprofen (1), Mefenamic acid (2) and ODTMA (3). 
 
 
Fig. 3. Hollow fiber (A) and spiral wound (B) modules. 
 
 
Fig. 4. Osmosis (A), osmotic pressure (B) and reverse osmosis (c) 
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Fig. 5. Flow diagram showing the process of wastewater treatment plant which consists of HF-UF filters (hollow fiber) and SW-UF 
(spiral wound), activated carbon and RO filters.  
 
 
Fig. 6. Calibration curve for ibuprofen using SPE. 
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Fig. 7. Chromatogram showing ibuprofen after 0 days in pure water. 
 
 
 
Fig. 8. Chromatogram showing ibuprofen after 30 days in pure water. 
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Fig. 9. Chromatogram showing ibuprofen after 0 days in wastewater. 
 
 
Fig. 10. Chromatogram showing ibuprofen after 30 days in wastewater. 
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Fig. 11. Adsorption of ibuprofen by clay micelle complex (ODTMA) at pH 4.0. 
 
Fig. 12. Adsorption of ibuprofen by clay micelle complex (ODTMA) at pH 8.0. 
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Fig. 13. Adsorption of ibuprofen by activated charcoal. 
 
 
Fig. 14. Langmuir isotherms for the removal of ibuprofen. 
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Fig. 15. Chromatograms showing the initial concentration of ibuprofen and after running the HF-UF point (see Fig. 5). 
 
 
Fig. 16. Chromatogram showing the concentration of ibuprofen before and after running the SW-UF point (see Fig. 5). 
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Fig. 17.Chromatogram showing the concentration of ibuprofen before and after running activated charcoal adsorbent point (see 
Fig. 5). 
 
Fig. 18. Chromatogram showing the concentration of ibuprofen after passing reverse osmosis (RO) membrane(see Fig. 5). 
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Fig. 19. Calibration curve by using SPE for mefenamic acid. 
 
 
Figure 20. Chromatogram showing mefenamic acid at 0 days in pure water. 
 
      Figure 21. Chromatogram showing mefenamic acid at 30 days in pure water. 
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Fig. 22. Calibration curve for mefenamic acid. 
 
Fig. 23. Adsorption of mefenamic acid by clay micelle complex (ODTMA). 
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Fig. 24. Adsorption of mefenamic acid by activated charcoal. 
 
 
 
 Fig. 25. Langmuir isotherms for the removal of mefenamic acid. 
 
 
 
 
 
 
 
 
 
 
Impact Factor 3.582   Case Studies Journal ISSN (2305-509X) – Volume 4, Issue 5 – May-2015 
http://www.casestudiesjournal.com  Page 64 
 
Fig. 26. Chromatogram showing the initial concentration of mefenamic acid before and after running the HF-UF point (Fig. 5). 
 
Fig. 27. Chromatogram showing the concentration of mefenamic acid before and after running the SW-UF point (Fig. 5). 
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Fig. 28. Chromatogram showing the concentration of mefenamic acid before and after running activated charcoal adsorbent 
point (Fig. 5). 
 
Fig. 29. Chromatogram showing the concentration of mefenamic acid after passing reverse osmosis (RO) membrane  (Fig. 5). 
Appendix B 
Table 1. Langmuir adsorption parameters (K and Qmax) of ibuprofen onto clay micelle complex and activated charcoal adsorbents 
Pharmaceutical Adsorbents Langmuir 
  K(L/mg) Qmax (mg/g) R² 
Ibuprofen Clay micelle 
complex 
 
0.64 ± 0.03 
 
62.5 ± 0.68  0.998 
Charcoal 0.65 ±0.03 66.7 ± 0.35 0.999 
* Results of K and Qmax are repeated as value ± SD; SD: standard deviation of three replicates  
Table 2. Langmuir adsorption parameters (K and Qmax) of Mefenamic acid onto clay micelle complex and activated charcoal 
adsorbents. 
Pharmaceutical Adsorbents Langmuir 
  K(L/mg) Qmax (mg/g) R² 
Mefenamic acid Clay micelle 
complex 
 
0.105 ± 
0.004 
100.0 ± 0.67 0.999 
Charcoal 0.065 ± 
0.003 
90.9 ± 0.74 0.99 
* Results of K and Qmax are repeated as value ± SD; SD: standard deviation of three replicates   
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Supplementary data   
 
Table S1. Wastewater treatment plants (WWTP) in the West Bank                         
Name of WWTP Effluent 
Quantity m
3
/d 
Type of Treatment 
Al Aroub 12-15 -Duckweed-based pond system 
-Small-scale biochemical system (JOHKASOU system) 
-Aeration tank 
Birzeit University 100 -Screen 
-Equalization tank 
-Activated sludge 
-Sand filters 
Deir-Samit-Hebron 40 -Sedimentation tank 
-Bio-filters 
Ieensnya-Nablus 40 -Septic tank 
-Anaerobic filter 
Nablus-west Salfit 25205 -Extended aeration 
Kharas- Hebron 120 -Anaerobic stage 
-Wetlands 
-Sludge drying 
-Effluent storage tank 
Sarha-Nablus 40 -Septic tank 
-Constructed wetland 
Al-Bireh 3200 -Screening 
-Aeration tanks 
-Disinfection by UV radiation  
Jenin 1500 -Aerated lagoon 
Ramallah 1370 - Two aerated lagoons 
Tulkarem 6742 -Stabilization ponds 
Tafuh 1370 -Anaerobic rock filtration 
Abu-Dees 2740 - Oxidation ditch 
Halhul 2740 -Aerated pond system 
Jarico 3290 ----------- 
Biddya 3000 ----------- 
Al-Ram 9000 -Aerobic sludge  
-Stabilization 
-Activated sludge 
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Table S2.Comparison of pressure-driven systems 
Parameters Membrane system 
Low- pressure membrane High- pressure membrane 
Microfiltration (MF) Ultrafiltration (UF) Nanofiltration (NF) Reverse Osmosis (RO) 
Product particle 
size (µm) 
0.08 to 2.0 
 
0.005 to 0.2 
 
0.001 to 0.01 
 
0.0001 to 0.001 
 
Retained 
compounds 
Very small suspended 
particles, some 
colloids, most bacteria 
 
Organic compounds > 
1000 Da, pyrogen, 
viruses, bacteria, 
colloids 
 
Organic compounds > 
200 Da, some 
dissolved solids (i.e. 
multivalent ions) 
 
Ions, Organic 
compounds >100 MW 
 
Operating 
pressure, psi 
1 to 15 
 
30 to 100 
 
80 to 125 
 
≥ 1,000 
 
 
Table S3. Percentage removal of ibuprofen by clay micelle complex (ODTMA) at pH 4.0. 
No. sample Time (minutes) % Removal 
1 0 0  
2 5 59.3 
3 10 59.7 
4 20 59.0 
5 30 59.6 
6 40 59.1 
7 50 58.8 
8 60 58.4 
9 80 58.2 
10 100 59.8 
11 120 59.1 
12 150 59.2 
13 180 59.6 
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Table S4. Percentage removal of ibuprofen by clay micelle complex (ODTMA) at pH 8.0. 
No. sample Time (minutes) % Removal 
1 0 0  
2 5 83.8 
3 10 84.6 
4 20 86.0 
5 30 86.7 
6 40 86.3 
7 50 87.2 
8 60 87.2 
9 80 88.7 
10 100 87.6 
11 120 88.2 
12 150 88.4 
13 180 90.3 
 
Table S5. Percentage removal of ibuprofen by activated charcoal. 
No. sample Time (minutes) % Removal 
1 0 0 
2 5 49.6 
3 10 52.3 
4 20 69.6 
5 30 82.3 
6 40 89.3 
7 50 91.9 
7 60 94.5 
8 80 96.1 
9 100 96.7 
10 120 97.8 
11 150 98.5 
12 180 99.1 
 
Table S6. Concentrations in equilibrium obtained for adsorption of ibuprofen onto the adsorbent clay micelle complex. 
Conc. (initial) 
(mgL-1) 
 
Mass 
(initial) 
(mg) 
 
Conc. (final) 
(mgL-1) 
(Ce) 
 
Mass 
(final) 
(mg) 
 
M initial - 
M final 
 
Qe= (M initial - M 
final) /0.5 g 
 
Ce/Qe 
 
48.8 ppm  4.88 0.56 ppm 0.056 4.824 9.648 0.06 
103.8 ppm  10.38 1.8 ppm 0.18 10.2 20.4 0.09 
208.6 ppm 20.86 20.2 ppm 2.02 18.84 37.68 0.54 
519.0 ppm 51.9 180.3 ppm 18.03 33.87 67.74 2.66 
988.6 ppm 98.86 686.6 ppm 68.66 28.62 60.4 11.36 
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Table S7. Concentrations in equilibrium obtained for adsorption of ibuprofen onto the adsorbent activated charcoal. 
Conc. (initial) (mgL-1) 
 
Mass 
(initial) 
(mg) 
 
Conc. (final) 
(mgL-1) 
(Ce) 
 
Mass 
(final) 
(mg) 
 
M initial 
- M final 
 
Qe= (M initial - M 
final) /0.5 g 
 
Ce/Qe 
 
52.0 ppm 5.2 0.28 ppm 0.028 5.172 10.344 0.027 
86.4 ppm 8.64 2.4 ppm 0.24 8.4 16.8 0.14 
184.6 ppm 18.46 1.6 ppm 0.16 18.3 36.6 0.043 
394.8 ppm 39.48 36.9 ppm 3.69 35.8 71.6 0.52 
835.6 ppm 83.56 513.3 ppm 51.33 32.23 64.46 8.0 
 
Table S8. Removal of ibuprofen through the hollow fiber (UF-HF), spiral wound (UF-SW), activated carbon adsorbent and reverse 
osmosis from the wastewater treatment plant at Al-Quds university. 
 
No. 
Sample location name Conc. of 
Ibuprofen (ppm) 
First trial 
Conc. of 
Ibuprofen 
(ppm) 
Second trial 
Conc. of 
Ibuprofen 
(ppm) 
Third trial 
 
1 
 
Blank (before addition of ibuprofen) 
 
0 
 
0 
 
0 
 
 
2 
 
The initial concentration of ibuprofen in storage tank (after 
addition of ibuprofen) 
 
37.1 
 
42.4 
 
40.0 
 
 
     
3 HF-UF Feed point 35.1 42.4 40.0 
 
Brine point 35.7 41.9 40.1 
 
Product point 9.7 15.3 23.4 
 
 
4 
 
HF-SW 
 
 
Concentrated UF   point 
 
2.0 
 
15.3 
 
23.4 
 
    
Permeated UF point 1.1 4.4 1.0 
 
 
5 
 
Activated carbon point 
 
 
0.27 
 
0.37 
 
0.83 
     
6 Reverse osmosis 
  (RO) 
Brine RO point 
 
0.24 0.04 0.82 
    
Permeated RO point 0.0 0.0 0.0 
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Table S9. Accumulative % removal of ibuprofen. 
Trial No. Hollow fiber (HF) Spiral wound (SW) Activated carbon Reverse osmosis 
(RO) 
1 73.9 % 97.1 % 99.3 % 99.8 % 
 
2 63.9 % 89.6 % 99.1 % 100.0 % 
 
3 41.5 %     97.5 % 97.9 % 99.9 % 
 
     
Average 59.8 % 94.7 % 98.8 % 99.9 % 
SD 16.6 4.5 0.76 0.1 
 
 
Table S10. Percentage removal of mefenamic acid by ODTMA complex  
No. sample Time (minutes) % Removal 
1 0 Zero 
2 5 96.9 
3 10 97.2 
4 20 98.5 
5 30 98.9 
6 40 98.1 
7 50 98.1 
7 60 97.5 
8 80 98.1 
9 100 98.0 
10 120 97.9 
11 150 97.3 
12 180 97.3 
 
Table S11. Percentage removal of mefenamic acid by charcoal. 
No. sample Time (minutes) % Removal 
1 0 Zero 
2 5 28.4 
3 10 37.2 
4 20 51.9 
5 30 60.9 
6 40 60.9 
7 50 74.2 
7 60 78.9 
8 80 85.3 
9 100 90.0 
10 120 93.0 
11 150 96.3 
12 180 97.2 
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Table S12. Concentrations in equilibrium obtained for adsorption of mefenamic acid onto the adsorbent clay micelle complex. 
Conc. (initial)  
(mgL-1) 
 
Mass 
(initial) 
(mg) 
 
Conc. 
(final) 
(mgL-1) 
(Ce) 
 
Mass 
(final) 
(mg) 
 
M initial - 
M final 
 
Qe= (M initial - M 
final) /0.5 g 
 
Ce/Qe 
 
48.1 4.81 1.9 0.19 4.62 9.24 0.206 
99.4 9.94 1.6 0.16 9.78 19.56 0.082 
199.2 19.92 5.5 0.55 19.37 38.74 0.15 
458.6 45.86 25.3 2.53 43.33 86.66 0.292 
983 98.3 501 50.1 48.2 96.4 5.20 
 
Table S13. Concentrations in equilibrium obtained for adsorption of mefenamic acid onto the adsorbent activated charcoal. 
Conc. (initial)  
(mgL-1) 
 
Mass 
(initial) 
(mg) 
 
Conc. 
(final) 
(mgL-1) 
(Ce) 
 
Mass 
(final) 
(mg) 
 
M initial - M 
final 
 
Qe= (M initial - M 
final) /0.5 g 
 
Ce/Qe 
 
49.3 4.93 0.16  0.016 4.914 9.83 0.016 
98.7 9.87 1.96  0.196 9.674 19.35 0.101 
194.7 19.47 5.5  0.550 18.92 37.84 0.145 
485.0 48.50 153.5  15.35 33.15 66.30 2.315 
989.0 98.90 537.8  53.78 45.12 90.24 5.960 
 
Table S14. Langmuir adsorption parameters (k and Qmax) of ibuprofen and mefenamic acid onto clay micelle complex and activated 
charcoal adsorbents. 
Adsorbent Ibuprofen Mefenamic acid 
 k (L/mg) 
 
Qmax (mg/g) 
 
k (L/mg) 
 
Qmax (mg/g) 
 
    
Clay micelle complex 
 
0.64 ± 0.03 
 
62.5 ± 0.68 0.105 ± 0.004 100.0 ± 0.67 
Charcoal 0.65 ±0.03 66.7 ± 0.35 0.065 ± 0.003 90.9 ± 0.74 
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Table S15. Removal of mefenamic acid by the hollow fiber (UF-HF), spiral wound (UF-SW), activated carbon adsorbent and reverse 
osmosis from the wastewater treatment plant.       
 
No. 
Sample location name Conc. of 
Mefenamic acid  
(ppm) 
First trial 
Conc. of 
Mefenamic acid  
(ppm) 
Second trial 
Conc. of 
Mefenamic acid  
(ppm) 
Third trial 
 
1 
 
Blank (before addition of Mefenamic acid) 
 
0 
 
0 
 
0 
 
     
2 The initial concentration of Mefenamic acid in 
storage tank (after addition of Mefenamic acid) 
42.0 40.0 39.5 
 
 
 
3 
 
HF-UF 
 
Feed point 
 
42.0 
 
37.9 
 
38.3 
 
 
Brine point 
 
18.0 
 
38.0 
 
36.0 
 
 
Product point 
 
 
1.1 
 
11.3 
 
18.4 
 
4 
 
HF-SW 
 
 
Concentrated UF   point 
 
1.1 
 
11.3 
 
16.0 
 
    
Permeated UF point 0.15 1.94 4.7 
 
 
5 
 
Activated carbon point 
 
0.12 
 
0.73 
 
0.60 
 
 
6 
 
Reverse osmosis 
  (RO) 
 
Brine RO point 
 
0.45 
 
0.72 
 
0.60 
 
    
Permeated RO point 0.07 0.0 0.5 
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Table S16. Accumulative % removal of mefenamic acid. 
Trial No. Hollow fiber (HF) Spiral wound (SW) Activated carbon Reverse osmosis 
(R.O) 
1 97.8 % 99.6 % 99.7 % 99.8 % 
 
2 71.8 % 95.2 % 98.2 % 100.0 % 
 
3 53.4 %     88.1 % 98.5 % 98.7 % 
     
Average 74.3 % 94.3 % 98.8 % 99.5 % 
SD 22.3 5.8 0.79 0.7 
 
 
Fig. S1. Chromatogram showing mefenamic acid after 0 days in wastewater 
 
              Fig. S2. Chromatogram showing mefenamic acid after 30 days in wastewater. 
